OtherBasic Science (Animal or Phantoms)
CC49 diabody pretargeting using click chemistry in vivo
Sander van Duijnhoven, Raffaella Rossin, Sandra van den Bosch, Michael Wheatcroft, Peter Hudson and Marc Robillard
Journal of Nuclear Medicine July 2015, jnumed.115.159145; DOI: https://doi.org/10.2967/jnumed.115.159145
Sander van Duijnhoven
1 Tagworks Pharmaceuticals, Netherlands;
Raffaella Rossin
1 Tagworks Pharmaceuticals, Netherlands;
Sandra van den Bosch
2 Philips Research, Netherlands;
Michael Wheatcroft
3 Avipep, Netherlands
Peter Hudson
3 Avipep, Netherlands
Marc Robillard
1 Tagworks Pharmaceuticals, Netherlands;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
CC49 diabody pretargeting using click chemistry in vivo
Sander van Duijnhoven, Raffaella Rossin, Sandra van den Bosch, Michael Wheatcroft, Peter Hudson, Marc Robillard
Journal of Nuclear Medicine Jul 2015, jnumed.115.159145; DOI: 10.2967/jnumed.115.159145
Jump to section
Related Articles
Cited By...
- Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab')2 Fragments of Obinutuzumab in Lymphoma
- Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy
- Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle
- Pretargeted Imaging and Therapy
- Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry
- Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers